Maximum time between cardiac cycles in atrial fibrillation for assessing the risk of arterial thromboembolism
Aim. To assess the development of thromboembolic events in different types of atrial fibrillation (AF), which differ in the maximum time between cardiac cycles.Material and methods. The main group included 80 patients with permanent AF, while the control one — 88 people without AF. The following inv...
Saved in:
| Main Authors: | O. A. Germanova, A. V. Germanov, Yu. V. Shchukin |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2022-08-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/5007 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-effectiveness of dabigatran for thromboembolic events prevention in atrial fibrillation patients in Chile
by: Tomás Abbot, et al.
Published: (2025-07-01) -
Optimal choice of prophylactic anticoagulant therapy for nonvalvular atrial fibrillation in the context of COVID-19 pandemic
by: A. S. Polyakov, et al.
Published: (2021-09-01) -
Factors determining adherence to anticoagulant therapy in patients with atrial fibrillation
by: D. V. Pevzner, et al.
Published: (2023-06-01) -
Atrial Fibrillation, Venous Thromboembolism, and Risk of Pulmonary Hypertension: A Swedish Nationwide Register Study
by: Clara Hjalmarsson, et al.
Published: (2025-05-01) -
Features of Thromboembolic and Hemorrhagic Complications in Planned Surgical Interventions in Patients with Atrial Fibrillation
by: L. N. Uddin, et al.
Published: (2019-07-01)